Roland Toder Ph.D

Roland Toder Ph.D General Information

Biography

Dr. Roland Toder serves as a Board Member and Partner at InsituGen. He co-founded Diasense. He served as Director of Business Development and Licensing at Footfalls & Heartbeats. He serves as Executive Director at Upstream Medical Technologies. He serves as a Partner at Pacific Channel. He is the Director of Business Development and International Licensing of Footfalls & Heartbeats. He has a sound commercial background interfacing with technological expertise in the life sciences sector. He brings on board skills in technology transfer, business development, venture capital fundraising, and sourcing a broad business network in Europe, Australia, and New Zealand. He is Executive Director of Akalpa, Lifescience Consulting Limited, and Partner at Life Science Consult. He is also a Non-Executive Director on the board of the publicly listed company Virax, Australia. He has also held various executive positions in Pharma and Biotechnology Companies in Europe, such as CEO of Vivendi Therapeutics Ltd., Basel, Switzerland where he raised a substantial amount of venture capital, he was co-founder and CEO of Axicos AG, Basel, Switzerland. Before that, he was also the CEO of BioChip Technologies GmbH, a subsidiary of GeneScan Europe AG, where he served as the CSO. With GeneScan Europe AG he facilitated a very successful IPO in 2000. He also founded GeneScan Australia Pty Ltd., where he was the Scientific Director and CEO. He has extensive life sciences and international business development expertise. He has previously worked as a manager, board member, and consultant to numerous successful companies in NZ and in Europe. He brings a wealth of knowledge to Pacific Channel and helps the team with technical due diligence, scientific validation, pre-money valuation of early start-ups, technology transfer, international licensing as well as advising on the commercial arrangements of our portfolio companies.